teriflunomide 14 MG Oral Tablet

1 INDICATIONS AND USAGE Teriflunomide tablets are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Teriflunomide is a pyrimidine synthesis inhibitor indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )

Amneal Pharmaceuticals NY LLC

FDA Reported Adverse Reactions
`[1] fatigue` `[2] nausea` `[3] drug ineffective` `[4] dyspnoea` `[5] pain` `[6] diarrhoea` `[7] headache` `[8] off label use` `[9] dizziness` `[10] vomiting`

4 years ago

ROUND BLUE AC 22

16 HOW SUPPLIED/STORAGE AND HANDLING

TERIFLUNOMIDE Tablets, 7 mg are pale green to green colored, round, biconvex coated tablet debossed with “AC” and “21” on one side and plain on other side. They are available as follows: Bottle of 28 Tablets: NDC 69238-1303-6 Carton of 28 Tablets: NDC 69238-1303-2 (1 wallet composed of 2 folded blister cards of 14 tablets per blister card)

TERIFLUNOMIDE Tablets, 14 mg are pale blue to blue colored, round, biconvex coated tablet debossed with “AC” and “22” on one side and plain on other side. They are available as follows: Bottle of 28 Tablets: NDC 69238-1304-6 Carton of 28 Tablets: NDC 69238-1304-2 (1 wallet composed of 2 folded blister cards of 14 tablets per blister card) Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].

More pills like ROUND AC 22

Related Pills

teriflunomide 7 MG Oral Tablet

Amneal Pharmaceuticals NY LLC

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site